Clinical Trial Update: The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of a buprenorphine transdermal patch for chronic low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Buprenorphine transdermal patch (buprenorphine)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Back Pain | Phase 3 | Status: COMPLETED